IP Library › Granted Patent US 9,283,316
Granted Patent B2
US 9,283,316 · App. 14/122,726 · Granted Mar 15, 2016

Priming anticoagulant alignment for blood extraction

Inventor: Greg Flexman (Cary, NC)
Assignee: GRIFOLS, S.A.
A61M1/3672A61M1/3643A61M1/3644A61M1/38A61M1/3496
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,316
App. No.
14/122,726
Granted
Mar 15, 2016
Kind
B2
Abstract

Methods and devices are described for reducing anticoagulant dilution of collected blood components during blood collection.

Claims (16)

1. A method of reducing anticoagulant dilution of collected blood components in a blood processing equipment, wherein the blood processing equipment comprises an anticoagulant reservoir ( 1 ) having an anticoagulant solution, a Y-connector and venous access device ( 5 ) having a cap ( 6 ), a blood component separation device ( 12 ), a line of anticoagulant ( 4 ) fluidly connecting the anticoagulant reservoir ( 1 ) to the Y-connector and venous access device ( 5 ), a blood withdraw/return line ( 7 ) fluidly connecting the Y-connector and venous access device ( 5 ) to the blood component separation device ( 12 ), an anticoagulant pump ( 2 ) fluidly connected to the line of anticoagulant ( 4 ), a liquid/air detector ( 3 ) fluidly connected to the line of anticoagulant ( 4 ), a withdraw/return pump ( 11 ) fluidly connected to the blood withdraw/return line ( 7 ), a pressure senor ( 9 ) fluidly connected to the blood withdraw/return line ( 7 ), and a liquid/air detector ( 8 ) fluidly connected to the blood withdraw/return line ( 7 ), the method comprising:

(a) priming and aligning the blood processing equipment with the anticoagulant solution comprising:

(i)synchronously pumping with pumps ( 2 , 11 ) to advance the anticoagulant solution from the anticoagulant reservoir ( 1 ) until the anticoagulant is detected by the air/fluid sensor ( 8 ); and

(ii) synchronously reverse pumping with pumps ( 2 , 11 ) to clear the line of anticoagulant ( 4 ) until an air/anticoagulant interface boundary is present in a priming anticoagulant alignment point ( 100 );

(b) connecting the venous-access device ( 5 ) to a donor;

(c) withdrawing whole blood from the donor such that the withdrawn whole blood is collected in the blood component separation device ( 12 ) for processing;

(d) separating the withdrawn whole blood into a first blood component and a second blood component in the blood component separation device ( 12 );

(e) extracting the first blood component from the blood component separation device ( 12 ); and

(f)returning the second blood component to the donor through the draw/return line ( 7 ).

2. The method of claim 1 , further comprising the following steps between step (i) and step (ii):

(1) confirming pump operation and tubing geometry by comparing the number of pump revolutions required to progress the anticoagulant between the liquid/air sensors ( 3 , 8 ) to pre-established expectations derived from understanding of pump displacement and tubing length; and

(2) confirming proper function of the pumps ( 2 , 11 ) and the cap ( 6 ) on the venous access device ( 5 ) by holding one pump fixed, and moving the other, while comparing the observed pressure change at the pressure sensor ( 9 ), to an expected change given the volume of fluid vs air expected in the lines; and

(3) annunciating any discrepancies to operator such that they can take appropriate action.

3. The method of claim 1 , wherein the blood processing equipment further comprises a first liquid/air detector and a second liquid/air detector, wherein the first fluid/air detector is fluidly connected to the withdraw/return line ( 7 ) and immediately adjacent to the venous-access device ( 5 ), and wherein the second liquid/air detector is fluidly connected to the withdraw/return line ( 7 ) and between the first liquid/air detector and the withdraw/return pump ( 11 ).

4. The method of claim 1 , wherein the first component comprises erythrocytes, leukocytes, platelets, or a combination thereof.

5. The method of claim 1 , wherein the second component comprises plasma.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 6, 2017
From: DEUTSCHE BANK AG NEW YORK BRANK
To: GRIFOLS THERAPEUTICS INC.; GRIFOLS SHARED SERVICES NORTH AMERICA INC.; GRIFOLS DIAGNOSTIC SOLUTIONS INC.
Reel/Frame 041638/0527 →
SECURITY AGREEMENT Recorded Feb 27, 2014
From: GRIFOLS INC.; GRIFOLS THERAPEUTICS INC.; GRIFOLS-CHIRON DIAGNOSTICS CORP.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032367/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2013
From: FLEXMAN, GREG
To: GRIFOLS, S.A.
Reel/Frame 031737/0653 →
Continuity (3)
Provisional Application 61490856 · May 27, 2011
Provisional Application 61493566 · Jun 6, 2011
Related Publication 20140100507A1 · Apr 10, 2014